We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

CTNS rs113994210: Understanding This Rare Genetic Variant

rs113994210
Trait
Moderate evidenceGene: CTNS

The rs113994210 variant is a rare genetic change located within the CTNS gene. It is associated with cystinosis, a rare autosomal recessive disorder characterized by the accumulation of cystine crystals in various tissues, including the eyes and kidneys.

What each genotype means

C/CLower attention

Typical CTNS gene profile

This genotype represents the common, non-pathogenic sequence at this position in the CTNS gene. Individuals with this profile do not carry the specific variant associated with ocular nonnephropathic cystinosis at this location.

This is the most common genotype observed in the general population.

C/GModerate attention

Carrier of variant

This genotype indicates that one copy of the CTNS gene carries the G variant, while the other copy is the common C allele. Because cystinosis is an autosomal recessive condition, carriers typically do not exhibit symptoms of the disease, though they should be aware of their carrier status for family planning purposes.

This genotype is rare in the general population.

G/GHigher attention

Associated with ocular cystinosis

This genotype is associated with ocular nonnephropathic cystinosis, a condition characterized by the accumulation of cystine crystals in the cornea and conjunctiva. Individuals with this genotype may experience symptoms such as photophobia, and should consult with an ophthalmologist or genetic counselor to discuss clinical monitoring and management.

This genotype is very rare in the general population.

What is the rs113994210 Variant?

The rs113994210 variant is a specific change in the DNA sequence of the CTNS gene. In genetics, a variant like this represents a difference in the nucleotide sequence compared to the most common version found in the general population. This particular variant is located on chromosome 17, where the CTNS gene resides. Because it is classified as a rare variant, it is not found in the vast majority of the human population. Geneticists study such variants to understand how specific alterations in the genetic code can disrupt the production or function of essential proteins. When a variant occurs in a gene as critical as CTNS, it can have significant biological consequences, potentially leading to the development of rare, inherited conditions that affect how cells process nutrients and waste products.

The Role of the CTNS Gene

The CTNS gene provides the essential instructions for building a protein called cystinosin. Cystinosin acts as a transporter located in the membrane of lysosomes, which are the cell's recycling centers. Its primary job is to move a substance called cystine out of the lysosome so it can be used or processed by the rest of the cell. When the CTNS gene is functioning normally, cystine levels within the lysosome remain balanced. However, if the gene contains pathogenic variants, the resulting cystinosin protein may be missing, shortened, or unable to perform its transport duties effectively. This leads to the buildup of cystine crystals inside the lysosomes, which can eventually damage cells and tissues throughout the body, particularly in organs like the kidneys and the eyes.

Research and Clinical Associations

Research into the CTNS gene has identified over 140 different pathogenic variants that contribute to various forms of cystinosis. The evidence linking specific variants in this gene to the disease is strong, as cystinosis is a well-characterized autosomal recessive lysosomal storage disorder. The rs113994210 variant is studied within this context, as researchers investigate how such changes disrupt the transport of cystine. While the clinical impact of a variant can vary depending on the specific nature of the mutation, variants in CTNS are generally associated with systemic phenotypes, including nephropathic (kidney-related) and non-nephropathic (ocular-related) cystinosis. Because cystinosis is rare, clinical data for specific rare variants like rs113994210 is often gathered through case studies and specialized genetic registries, which help clinicians understand the spectrum of the disease and the potential for future therapeutic interventions.

Population Frequency and Interpretation

The rs113994210 variant is considered rare across global populations. In genetic studies, rare variants are those that appear at a very low frequency in the general population, often making them difficult to study without large-scale genomic databases. Because this variant is associated with an autosomal recessive condition, an individual would typically need to inherit two copies of a pathogenic variant—one from each parent—to manifest the clinical symptoms of cystinosis. If you have received information about this variant from a genetic test, it is important to remember that genetic results are complex. A single variant does not necessarily equate to a diagnosis. You should always discuss your specific genetic findings with a qualified healthcare provider or a genetic counselor who can interpret the results in the context of your personal and family medical history.

How common is this variant?

The rs113994210 variant is rare in the general population, with its frequency varying significantly across different ancestral groups.

Frequently asked questions

What is cystinosis?

Cystinosis is a rare, inherited lysosomal storage disorder where the amino acid cystine accumulates in cells. This buildup forms crystals that can damage organs, most notably the kidneys and the eyes.

Is rs113994210 a diagnosis for cystinosis?

No, identifying a single genetic variant is not a medical diagnosis. A diagnosis of cystinosis requires a comprehensive clinical evaluation, including physical exams and specialized testing by a medical professional.

What should I do if my report shows this variant?

If your genetic report mentions this variant, you should consult with a genetic counselor or your primary care physician. They can help you understand what the result means for your health and whether further clinical testing is necessary.

Are there treatments for CTNS-related conditions?

Yes, there are medical management strategies for cystinosis, including medications that help deplete cystine levels in the body. Treatment plans are highly individualized and must be managed by a specialist, such as a nephrologist or ophthalmologist.

Sources & further reading

Educational information only, last refreshed 9/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs113994210?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29